{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:04:10Z","timestamp":1776067450713,"version":"3.50.1"},"reference-count":418,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR073270"],"award-info":[{"award-number":["R01AR073270"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.smim.2022.101648","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T23:28:28Z","timestamp":1659742108000},"page":"101648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Cellular and Molecular Diversity in Scleroderma"],"prefix":"10.1016","volume":"58","author":[{"given":"Monique","family":"Hinchcliff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolando","family":"Garcia-Milian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Di Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Dill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Bundschuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Del","family":"Galdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib2","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2013-204487","article-title":"Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis","volume":"74","author":"Moinzadeh","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib4","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1136\/ard.2007.069518","article-title":"Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis","volume":"66","author":"Clements","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib5","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1378\/chest.12-2396","article-title":"Systemic sclerosis-associated pulmonary arterial hypertension","volume":"144","author":"Chaisson","year":"2013","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.55563\/clinexprheumatol\/izadb8","article-title":"One year in review 2021: systemic sclerosis","volume":"39 Suppl 131","author":"Di Battista","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib7","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/S2665-9913(20)30007-2","article-title":"Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials","volume":"2","author":"Del Galdo","year":"2020","journal-title":"Lancet Rheumatol."},{"issue":"6167","key":"10.1016\/j.smim.2022.101648_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1126\/science.1246886","article-title":"Association of the autoimmune disease scleroderma with an immunologic response to cancer","volume":"343","author":"Joseph","year":"2014","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002091","article-title":"Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis","volume":"7","author":"Allanore","year":"2011","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib10","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/art.24734","article-title":"Clinical and genetic factors predictive of mortality in early systemic sclerosis","volume":"61","author":"Assassi","year":"2009","journal-title":"Arthritis Care Res."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/rheumatology\/key281","article-title":"Analysis of the genetic component of systemic sclerosis in Iranian and Turkish populations through a genome-wide association study","volume":"58","author":"Gonz\u00e1lez-Serna","year":"2018","journal-title":"Rheumatology"},{"issue":"7653","key":"10.1016\/j.smim.2022.101648_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nature22329","article-title":"Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells","volume":"545","author":"Ooi","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib14","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.4049\/jimmunol.181.4.2869","article-title":"Delineating the role of the HLA-DR4 \u201cShared Epitope\u201d in susceptibility versus resistance to develop arthritis","volume":"181","author":"Taneja","year":"2008","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib15","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1002\/art.24958","article-title":"Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1\/Th2 cytokines","volume":"60","author":"Gourh","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib16","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/art.40541","article-title":"Brief report: whole-exome sequencing to identify rare variants and gene networks that increase susceptibility to scleroderma in African Americans","volume":"70","author":"Gourh","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib17","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/art.39721","article-title":"Brief report: whole-exome sequencing for identification of potential causal variants for diffuse cutaneous systemic sclerosis","volume":"68","author":"Mak","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ejhg.2013.96","article-title":"Phenotype-genotype integrator (PheGenI): synthesizing genome-wide association study (GWAS) data with existing genomic resources","volume":"22","author":"Ramos","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"issue":"D1","key":"10.1016\/j.smim.2022.101648_bib19","doi-asserted-by":"crossref","first-page":"D985","DOI":"10.1093\/nar\/gkw1055","article-title":"Open targets: a platform for therapeutic target identification and validation","volume":"45","author":"Koscielny","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1741-7015-11-9","article-title":"Genetics of scleroderma: implications for personalized medicine?","volume":"11","author":"Assassi","year":"2013","journal-title":"BMC Med."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002696","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"Milano","year":"2008","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib22","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/jid.2013.130","article-title":"Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis","volume":"133","author":"Hinchcliff","year":"2013","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.smim.2022.101648_bib23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13075-015-0669-3","article-title":"Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis","volume":"17","author":"Chakravarty","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"10038","key":"10.1016\/j.smim.2022.101648_bib24","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/art.24221","article-title":"Molecular framework for response to imatinib mesylate in systemic sclerosis","volume":"60","author":"Chung","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2022.101648_bib27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13075-015-0721-3","article-title":"Nilotinib (Tasigna) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial","volume":"17","author":"Gordon","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.smim.2022.101648_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/art.41294","article-title":"Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with systemic sclerosis","author":"Spiera","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.55563\/clinexprheumatol\/i80zh7","article-title":"A randomised, double-blind, placebo-controlled phase 3 study of lenabasum in diffuse cutaneous systemic sclerosis: RESOLVE-1 design and rationale","volume":"39 Suppl 131","author":"Spiera","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"issue":"7479","key":"10.1016\/j.smim.2022.101648_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature12783","article-title":"Distinct fibroblast lineages determine dermal architecture in skin development and repair","volume":"504","author":"Driskell","year":"2013","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib31","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1038\/s41467-021-24607-6","article-title":"Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin","volume":"12","author":"Tabib","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib32","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1440-1711.2005.01342.x","article-title":"Antibody blockade of Thy-1 (CD90) impairs mouse cytotoxic T lymphocyte induction by anti-CD3 monoclonal antibody","volume":"83","author":"Haeryfar","year":"2005","journal-title":"Immunol. Cell Biol."},{"issue":"24","key":"10.1016\/j.smim.2022.101648_bib33","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.3390\/jcm10245820","article-title":"SFRP4 expression is linked to immune-driven fibrotic conditions, correlates with skin and lung fibrosis in ssc and a potential EMT biomarker","volume":"10","author":"Tinazzi","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.smim.2022.101648_bib34","unstructured":"Xue, D., et al., Expansion of FCGR3A+ macrophages, FCN1+ mo-DC, and plasmacytoid dendritic cells associated with severe skin disease in systemic sclerosis. Arthritis & Rheumatology. n\/a(n\/a)."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib35","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/annrheumdis-2020-218439","article-title":"Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma","volume":"80","author":"Ross","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib36","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/annrheumdis-2018-214865","article-title":"Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease","volume":"78","author":"Valenzi","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib37","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1038\/s41467-020-15647-5","article-title":"Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis","volume":"11","author":"Tsukui","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2022.101648_bib38","doi-asserted-by":"crossref","DOI":"10.1165\/rcmb.2021-0356OC","article-title":"Lung injury induces alveolar type 2 cell hypertrophy and polyploidy with implications for repair and regeneration","author":"Weng","year":"2022","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0000000000000656","article-title":"Biomarkers in systemic sclerosis","volume":"31","author":"Skaug","year":"2019","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/annrheumdis-2012-202843","article-title":"The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis","volume":"73","author":"Abignano","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib41","first-page":"254","article-title":"European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis","volume":"58","author":"Abignano","year":"2019","journal-title":"Rheumatol. (Oxf. )"},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib42","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3899\/jrheum.160339","article-title":"Elevated serum krebs von den lungen-6 in early disease predicts subsequent deterioration of pulmonary function in patients with systemic sclerosis and interstitial lung disease","volume":"43","author":"Kuwana","year":"2016","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib43","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3899\/jrheum.170518","article-title":"KL-6 but not CCL-18 is a predictor of early progression in systemic sclerosis-related interstitial lung disease","volume":"45","author":"Salazar","year":"2018","journal-title":"J. Rheuma"},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib44","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.41020","article-title":"Progression of interstitial lung disease in systemic sclerosis: the importance of pneumoproteins krebs von den lungen 6 and CCL18","volume":"71","author":"Volkmann","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib45","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/acr.21968","article-title":"Does C-reactive protein predict the long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis?","volume":"65","author":"Liu","year":"2013","journal-title":"Arthritis Care Res. (Hoboken)"},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.smim.2022.101648_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40674-016-0050-y","article-title":"Autoantibodies and their role in scleroderma clinical care","volume":"2","author":"Domsic","year":"2016","journal-title":"Curr. Treat. Options Rheum."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib48","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1136\/annrheumdis-2021-220402","article-title":"Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis","volume":"80","author":"Clark","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib49","first-page":"101","article-title":"Candidate proteomic biomarkers in systemic sclerosis discovered using mass-spectrometry: an update of a systematic review (2014\u20132020)","volume":"59","author":"B\u0103l\u0103nescu","year":"2021","journal-title":"Rom. J. Intern. Med."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13075-021-02633-5","article-title":"Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?","volume":"23","author":"Farutin","year":"2021","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib51","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/art.41627","article-title":"Predictive significance of serum interferon-inducible protein score for response to treatment in systemic sclerosis\u2013related interstitial lung disease","volume":"73","author":"Assassi","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib52","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/annrheumdis-2019-215770","article-title":"Myeloablation followed by autologous stem cell transplantation normalises systemic sclerosis molecular signatures","volume":"78","author":"Assassi","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"9790","key":"10.1016\/j.smim.2022.101648_bib53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib54","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir. Med."},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib55","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1513\/AnnalsATS.201802-079OC","article-title":"Longitudinal changes in quantitative interstitial lung disease on computed tomography after immunosuppression in the scleroderma lung study II","volume":"15","author":"Goldin","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib56","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.acra.2008.03.011","article-title":"Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study","volume":"15","author":"Kim","year":"2008","journal-title":"Acad. Radiol."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib57","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s00330-011-2223-2","article-title":"Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide","volume":"21","author":"Kim","year":"2011","journal-title":"Eur. Radiol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib58","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13075-020-2127-0","article-title":"High-throughput quantitative histology in systemic sclerosis skin disease using computer vision","volume":"22","author":"Correia","year":"2020","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib59","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13075-020-02392-9","article-title":"Computer vision applied to dual-energy computed tomography images for precise calcinosis cutis quantification in patients with systemic sclerosis","volume":"23","author":"Chandrasekaran","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.smim.2022.101648_bib60","article-title":"First pilot study of extracellular volume MRI measurement in peripheral muscle of systemic sclerosis patients suggests diffuse fibrosis","author":"Dumitru","year":"2021","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.smim.2022.101648_bib61","article-title":"Digital artery volume index (Davix\u00a9) predicts onset of future digital ulcers in patients with systemic sclerosis [abstract]","volume":"72","author":"Gjeloshi","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib62","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/art.40906","article-title":"Phenotypes determined by cluster analysis and their survival in the prospective european scleroderma trials and research cohort of patients with systemic sclerosis","volume":"71","author":"Sobanski","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib63","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3899\/jrheum.160045","article-title":"Analysis of systemic sclerosis-associated genes in a Turkish population","volume":"43","author":"Carmona","year":"2016","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.smim.2022.101648_bib64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1874312901408010029","article-title":"Systemic sclerosis is a complex disease associated mainly with immune regulatory and inflammatory genes","volume":"8","author":"Jin","year":"2014","journal-title":"Open Rheumatol. J."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ajhg.2013.12.002","article-title":"Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis","volume":"94","author":"Mayes","year":"2014","journal-title":"Am. J. Hum. Genet"},{"issue":"51","key":"10.1016\/j.smim.2022.101648_bib66","first-page":"134","article-title":"The genetics of systemic sclerosis","volume":"10","author":"Agarwal","year":"2010","journal-title":"Discov. Med."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/BOR.0b013e3283367c17","article-title":"The genetics of scleroderma (systemic sclerosis)","volume":"22","author":"Agarwal","year":"2010","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib68","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/rheumatology\/kep368","article-title":"Genetic background of systemic sclerosis: autoimmune genes take centre stage","volume":"49","author":"Allanore","year":"2010","journal-title":"Rheumatol. (Oxf. )"},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib69","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/art.30379","article-title":"C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large french cohort and meta-analysis","volume":"63","author":"Coustet","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib70","first-page":"839","article-title":"Association study of B-cell marker gene polymorphisms in European Caucasian patients with systemic sclerosis","volume":"29","author":"Dawidowicz","year":"2011","journal-title":"Clin. Exp. Rheuma"},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib71","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.autrev.2010.09.017","article-title":"Immunogenetics of systemic sclerosis","volume":"10","author":"Dieud\u00e9","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib72","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1002\/art.24885","article-title":"BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4","volume":"60","author":"Dieud\u00e9","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib73","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00393-010-0691-4","article-title":"[Genetic analysis in collagen vascular diseases]","volume":"70","author":"Melchers","year":"2011","journal-title":"Z. Rheumatol."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib74","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/ard.2009.118174","article-title":"BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians","volume":"69","author":"Rueda","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113197","article-title":"Possible single-nucleotide polymorphism loci associated with systemic sclerosis susceptibility: a genetic association study in a Chinese Han population","volume":"9","author":"Shu","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib76","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/BOR.0000000000000735","article-title":"Systemic sclerosis pathogenesis: contribution of recent advances in genetics","volume":"32","author":"Orvain","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004005","article-title":"Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms","volume":"11","author":"Mahoney","year":"2015","journal-title":"PLoS Comput. Biol."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib78","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/art.27303","article-title":"Association of the FAM167A-BLK region with systemic sclerosis","volume":"62","author":"Ito","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib79","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaut.2009.08.014","article-title":"Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations","volume":"34","author":"Gourh","year":"2010","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib80","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2133.2009.09507.x","article-title":"CCL13 is a promising diagnostic marker for systemic sclerosis","volume":"162","author":"Yanaba","year":"2010","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib81","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2133.2011.10330.x","article-title":"Serum CCL13 levels in patients with systemic sclerosis and controls","volume":"165","author":"Gambichler","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib82","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1093\/rheumatology\/keu246","article-title":"Involvement of CD161+ V\u03b41+ \u03b3\u03b4 T cells in systemic sclerosis: association with interstitial pneumonia","volume":"53","author":"Segawa","year":"2014","journal-title":"Rheumatol. (Oxf.)"},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib83","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/dna.2019.4780","article-title":"In silico detection and characterization of microRNAs and their target genes in microRNA microarray datasets from patients with systemic sclerosis-interstitial lung disease","volume":"38","author":"He","year":"2019","journal-title":"DNA Cell Biol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib84","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2249.1999.00929.x","volume":"117","author":"Hasegawa","year":"1999","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib85","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/ard.2010.137349","article-title":"An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis","volume":"70","author":"Codullo","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib86","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00011-017-1106-7","article-title":"Increased frequencies of circulating CXCL10-, CXCL8- and CCL4-producing monocytes and Siglec-3-expressing myeloid dendritic cells in systemic sclerosis patients","volume":"67","author":"Carvalheiro","year":"2018","journal-title":"Inflamm. Res."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib87","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/art.1780400422","article-title":"Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis","volume":"40","author":"Bolster","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib88","first-page":"274","article-title":"Serum cytokines and their predictive value in pulmonary involvement of systemic sclerosis","volume":"36","author":"Becker","year":"2019","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib89","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00296-017-3722-5","article-title":"The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms","volume":"37","author":"Zhao","year":"2017","journal-title":"Rheuma Int"},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib90","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s10067-019-04922-6","article-title":"Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease","volume":"39","author":"Stock","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib91","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/art.30204","article-title":"Association of the CD226 Ser(307) variant with systemic sclerosis: evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis","volume":"63","author":"Dieud\u00e9","year":"2011","journal-title":"Arthritis Rheumtol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib92","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/ar3809","article-title":"A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis","volume":"14","author":"Bossini-Castillo","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib93","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4049\/jimmunol.1403046","article-title":"Increased CD226 expression on CD8+ T cells is associated with upregulated cytokine production and endothelial cell injury in patients with systemic sclerosis","volume":"195","author":"Ayano","year":"2015","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib94","first-page":"471","article-title":"Association Study of CD226 and CD247 genes single nucleotide polymorphisms in iranian patients with systemic sclerosis","volume":"16","author":"Abbasi","year":"2017","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"10.1016\/j.smim.2022.101648_bib95","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2017.05.004","article-title":"Unfolding the pathogenesis of scleroderma through genomics and epigenomics","volume":"83","author":"Tsou","year":"2017","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib96","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/annrheumdis-2011-200901","article-title":"IRF5 polymorphism predicts prognosis in patients with systemic sclerosis","volume":"71","author":"Sharif","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib97","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat. Genet"},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib98","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1136\/ard.2010.147009","article-title":"Independent replication establishes the CD247 gene as a genetic systemic sclerosis susceptibility factor","volume":"70","author":"Dieud\u00e9","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib99","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.humimm.2016.10.017","article-title":"Genomic and genetic studies of systemic sclerosis: a systematic review","volume":"78","author":"Chairta","year":"2017","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s13075-014-0438-8","article-title":"An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3","volume":"16","author":"Zochling","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib101","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.3892\/mmr.2020.11547","article-title":"Association of the DNASE1L3 rs35677470 polymorphism with systemic lupus erythematosus, rheumatoid arthritis and systemic sclerosis: Structural biological insights","volume":"22","author":"Zervou","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib102","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/art.22036","article-title":"Endothelin axis polymorphisms in patients with scleroderma","volume":"54","author":"Fonseca","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib103","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/s41467-018-07598-9","article-title":"GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis","volume":"9","author":"Cabral-Marques","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib104","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13075-016-1011-4","article-title":"Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice","volume":"18","author":"Akashi","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.smim.2022.101648_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642891","article-title":"Elevated fibronectin levels in profibrotic CD14(+) monocytes and CD14(+) macrophages in systemic sclerosis","volume":"12","author":"Rudnik","year":"2021","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib106","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/annrheumdis-2018-214778","article-title":"Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis","volume":"78","author":"Moon","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib107","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.39421","article-title":"Endothelial cells expressing endothelial and mesenchymal cell gene products in lung tissue from patients with systemic sclerosis-associated interstitial lung disease","volume":"68","author":"Mendoza","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib108","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/jcp.24337","article-title":"Interferon-\u03b3 promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)-1 and transforming growth factor (TGF) \u03b22","volume":"228","author":"Chrobak","year":"2013","journal-title":"J. Cell Physiol."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib109","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/1756-185X.13386","article-title":"5-HT(2) and 5-HT(2B) antagonists attenuate pro-fibrotic phenotype in human adult dermal fibroblasts by blocking TGF-\u03b21 induced non-canonical signaling pathways including STAT3: implications for fibrotic diseases like scleroderma","volume":"21","author":"Chaturvedi","year":"2018","journal-title":"Int J. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002178","article-title":"Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy","volume":"7","author":"Gorlova","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.smim.2022.101648_bib111","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.clim.2017.04.013","article-title":"IL-10-producing regulatory B cells (B10 cells), IL-17+ T cells and autoantibodies in systemic sclerosis","volume":"184","author":"Mavropoulos","year":"2017","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib112","first-page":"23","article-title":"Anti-fibrotic characteristics of V\u03b39+ \u03b3\u03b4 T cells in systemic sclerosis","volume":"34 Suppl 100","author":"Markovits","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"issue":"19","key":"10.1016\/j.smim.2022.101648_bib113","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1093\/hmg\/ddt248","article-title":"A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci","volume":"22","author":"Martin","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib114","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1002\/art.38870","article-title":"Identification of IL12RB1 as a novel systemic sclerosis susceptibility locus","volume":"66","author":"L\u00f3pez-Isac","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13073-020-00779-6","article-title":"Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci","volume":"12","author":"Li","year":"2020","journal-title":"Genome Med."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib116","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/hmg\/ddr522","article-title":"A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations","volume":"21","author":"Bossini-Castillo","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib117","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/s41598-020-58741-w","article-title":"A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn\u2019s disease","volume":"10","author":"Gonz\u00e1lez-Serna","year":"2020","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib118","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41409-018-0162-0","article-title":"Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis","volume":"53","author":"Arruda","year":"2018","journal-title":"Bone Marrow Transpl."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib119","first-page":"198","article-title":"IL-17 and Th17 cells in systemic sclerosis: a comprehensive review","volume":"55","author":"B\u0103l\u0103nescu","year":"2017","journal-title":"Rom. J. Intern Med."},{"key":"10.1016\/j.smim.2022.101648_bib120","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5523582","article-title":"Investigation of newly diagnosed drug-naive patients with systemic autoimmune diseases revealed the cleaved peptide tyrosine tyrosine (PYY 3-36) as a specific plasma biomarker of rheumatoid arthritis","volume":"2021","author":"Balog","year":"2021","journal-title":"Mediators Inflamm."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib121","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar4334","article-title":"Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts","volume":"15","author":"Brembilla","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.smim.2022.101648_bib122","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.imlet.2018.03.011","article-title":"Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations","volume":"198","author":"Dantas","year":"2018","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.smim.2022.101648_bib123","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.steroids.2017.08.012","article-title":"Corticosteroid inhibits chemokines production in systemic sclerosis patients","volume":"127","author":"Dantas","year":"2017","journal-title":"Steroids"},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib124","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10787-019-00600-w","article-title":"Dexamethasone inhibits cytokine production in PBMC from systemic sclerosis patients","volume":"27","author":"de Almeida","year":"2019","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.smim.2022.101648_bib125","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.3389\/fimmu.2018.01865","article-title":"Interleukin-6 and Type-I collagen production by systemic sclerosis fibroblasts are differentially regulated by interleukin-17A in the presence of transforming growth factor-beta 1","volume":"9","author":"Dufour","year":"2018","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib126","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jid.2019.05.026","article-title":"IL-17A dissociates inflammation from fibrogenesis in systemic sclerosis","volume":"140","author":"Dufour","year":"2020","journal-title":"J. Invest Dermatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib127","doi-asserted-by":"crossref","first-page":"17721","DOI":"10.1038\/s41598-019-54132-y","article-title":"TH17 cells expressing CD146 are significantly increased in patients with systemic sclerosis","volume":"9","author":"Gabsi","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.semarthrit.2012.03.014","article-title":"Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines","volume":"42","author":"Hasegawa","year":"2012","journal-title":"Semin Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/cei.13651","article-title":"Body mass index and adipokines\/cytokines dysregulation in systemic sclerosis","volume":"206","author":"Iannone","year":"2021","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.6061\/clinics\/2015(04)06","article-title":"Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway","volume":"70","author":"Liu","year":"2015","journal-title":"Clin. (Sao Paulo)"},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib131","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1186\/s13075-014-0512-2","article-title":"Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway","volume":"16","author":"Liu","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105008","article-title":"High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis","volume":"9","author":"Lonati","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2022.101648_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106282","article-title":"The risk of circulating angiogenic T cells and subsets in patients with systemic sclerosis","volume":"81","author":"Lv","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib134","first-page":"269","article-title":"Th17 pathway genes polymorphisms in Algerian patients with systemic sclerosis","volume":"43","author":"Mellal","year":"2018","journal-title":"Acta Reum. Port."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib135","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib136","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts","volume":"188","author":"Nakashima","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib137","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/10\/4\/046013","article-title":"Th-17 cytokines and interstitial lung involvement in systemic sclerosis","volume":"10","author":"Rolla","year":"2016","journal-title":"J. Breath. Res"},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib138","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s00296-018-4071-8","article-title":"Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis","volume":"38","author":"Tang","year":"2018","journal-title":"Rheuma Int."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib139","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1136\/annrheumdis-2012-201400","article-title":"Prostaglandin I(2) analogues enhance already exuberant Th17 cell responses in systemic sclerosis","volume":"71","author":"Truchetet","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib140","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar3486","article-title":"Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease","volume":"13","author":"Truchetet","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib141","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/art.37860","article-title":"Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement","volume":"65","author":"Truchetet","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.smim.2022.101648_bib142","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fimmu.2020.00220","article-title":"T-cell proapoptotic and antifibrotic activity against autologous skin fibroblasts in vitro is associated with IL-17A axis upregulation in systemic sclerosis","volume":"11","author":"Vettori","year":"2020","journal-title":"Front Immunol."},{"issue":"23","key":"10.1016\/j.smim.2022.101648_bib143","doi-asserted-by":"crossref","first-page":"13600","DOI":"10.1111\/jcmm.15266","article-title":"IFN-\u03b3(+) IL-17(+) Th17 cells regulate fibrosis through secreting IL-21 in systemic scleroderma","volume":"24","author":"Xing","year":"2020","journal-title":"J. Cell Mol. Med"},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085032","article-title":"IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway","volume":"8","author":"Xing","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2022.101648_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106644","article-title":"A novel bispecific antibody alleviates bleomycin-induced systemic sclerosis injury","volume":"85","author":"Yin","year":"2020","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib146","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jid.2019.07.678","article-title":"IL-17A softens the skin: antifibrotic properties of IL-17A in systemic sclerosis","volume":"140","author":"Zeng","year":"2020","journal-title":"J. Invest Dermatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib147","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s13075-019-2074-9","article-title":"DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis models","volume":"21","author":"Zhang","year":"2019","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib148","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.humimm.2014.12.008","article-title":"The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis","volume":"76","author":"Zhou","year":"2015","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib149","first-page":"716","article-title":"Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms","volume":"51","author":"Zhu","year":"2019","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib150","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/iji.12212","article-title":"IL-1A rs1800587, IL-1B rs1143634 and IL-1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis","volume":"42","author":"Abtahi","year":"2015","journal-title":"Int J. Immunogenet."},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib151","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1093\/rheumatology\/keaa230","article-title":"Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis","volume":"59","author":"Arvia","year":"2020","journal-title":"Rheumatol. (Oxf.)"},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib152","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s12026-016-8797-7","article-title":"Association of interleukin-1 family cytokines single nucleotide polymorphisms with susceptibility to systemic sclerosis: an independent case-control study and a meta-analysis","volume":"64","author":"Huang","year":"2016","journal-title":"Immunol. Res."},{"key":"10.1016\/j.smim.2022.101648_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102547","article-title":"Integrated bulk and single-cell RNA-sequencing identified disease-relevant monocytes and a gene network module underlying systemic sclerosis","volume":"116","author":"Kobayashi","year":"2021","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib154","first-page":"997","article-title":"Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis","volume":"34","author":"Mattuzzi","year":"2007","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib155","first-page":"56","article-title":"Role of interleukin-1 and interleukin-2 in the pathogenesis of systemic scleroderma","volume":"48","author":"Ne\u012dko","year":"2002","journal-title":"Fiziol. Zh."},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/cells9092106","article-title":"Gastric juice expression of Th-17 and T-Reg related cytokines in scleroderma esophageal involvement","volume":"9","author":"Nicola","year":"2020","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012106","article-title":"Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury","volume":"5","author":"Pendergrass","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib158","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/art.39817","article-title":"Platelets induce thymic stromal lymphopoietin production by endothelial cells: contribution to fibrosis in human systemic sclerosis","volume":"68","author":"Truchetet","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib159","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3899\/jrheum.090421","article-title":"Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis","volume":"36","author":"Agarwal","year":"2009","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/ard.2007.072819","article-title":"Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis","volume":"67","author":"Farag\u00f3","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib161","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005903","article-title":"The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes","volume":"4","author":"Radstake","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib162","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.2008.096719","article-title":"The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype","volume":"68","author":"Rueda","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib163","first-page":"321","article-title":"Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement","volume":"33","author":"Abdel-Magied","year":"2016","journal-title":"Sarcoidosis Vasc. Diffus. Lung Dis."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib164","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00296-020-04732-z","article-title":"Tocilizumab therapy in juvenile systemic sclerosis: a retrospective single centre pilot study","volume":"41","author":"Adrovic","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10067-021-05887-1","article-title":"Cardiac calcium score in systemic sclerosis","volume":"41","author":"Afifi","year":"2022","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib166","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/ar3221","article-title":"Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts","volume":"13","author":"Agarwal","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib167","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00296-019-04317-5","article-title":"Interleukin-17 pathways in systemic sclerosis-associated fibrosis","volume":"39","author":"Ahmed","year":"2019","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib168","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/07853890.2013.771986","article-title":"Tocilizumab: a novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases","volume":"45","author":"Alten","year":"2013","journal-title":"Ann. Med."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib169","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-3083.2011.02567.x","article-title":"Cytokine mRNA profile of alveolar T lymphocytes and macrophages in patients with systemic sclerosis suggests a local Tr1 response","volume":"74","author":"Andersen","year":"2011","journal-title":"Scand. J. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib170","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3899\/jrheum.111132","article-title":"Systemic sclerosis fibroblasts show specific alterations of interferon-\u03b3 and tumor necrosis factor-\u03b1-induced modulation of interleukin 6 and chemokine ligand 2","volume":"39","author":"Antonelli","year":"2012","journal-title":"J. Rheumatol."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib171","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/03009742.2011.585349","article-title":"IFN-\u03b3 and TNF-\u03b1 induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls","volume":"40","author":"Antonelli","year":"2011","journal-title":"Scand. J. Rheuma"},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib172","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3109\/08916934.2013.812080","article-title":"Functional implications of IgG anti-endothelial cell antibodies in pulmonary arterial hypertension","volume":"46","author":"Arends","year":"2013","journal-title":"Autoimmunity"},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib173","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/BOR.0000000000000827","article-title":"Biomarkers in systemic sclerosis: mechanistic insights into pathogenesis and treatment","volume":"33","author":"Arron","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2 Suppl 81","key":"10.1016\/j.smim.2022.101648_bib174","first-page":"165","article-title":"Targeted immunotherapies in systemic sclerosis","volume":"32","author":"Avouac","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib175","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/annrheumdis-2012-201759","article-title":"Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis","volume":"72","author":"Avouac","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib176","first-page":"44","article-title":"IL-17, IL-6 and IFN-\u03b3 in systemic sclerosis patients","volume":"53","author":"B\u0103l\u0103nescu","year":"2015","journal-title":"Rom. J. Intern Med."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib177","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s10067-019-04459-8","article-title":"Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile","volume":"38","author":"Ba\u00f1os-Hern\u00e1ndez","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib178","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/ard.2010.133587","article-title":"Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis?","volume":"70","author":"Barnes","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib179","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/039463201102400134","article-title":"Evaluation of the effect of Bosentan treatment on proinflammatory cytokine serum levels in patients affected by Systemic Sclerosis","volume":"24","author":"Bellisai","year":"2011","journal-title":"Int J. Immunopathol. Pharm."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib180","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejim.2010.05.010","article-title":"A 3-factor epistatic model predicts digital ulcers in Italian scleroderma patients","volume":"21","author":"Beretta","year":"2010","journal-title":"Eur. J. Intern Med."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib181","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/rheumatology\/kew365","article-title":"Comparison of change in end tidal carbon dioxide after three minutes of step exercise between systemic sclerosis patients with and without pulmonary hypertension","volume":"56","author":"Bernstein","year":"2017","journal-title":"Rheumatol. (Oxf. )"},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib182","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.41243","article-title":"Profibrotic activation of human macrophages in systemic sclerosis","volume":"72","author":"Bhandari","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib183","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jclinpath-2017-204656","article-title":"Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu","volume":"71","author":"Bosello","year":"2018","journal-title":"J. Clin. Pathol."},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib184","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.autrev.2011.04.013","article-title":"B cells in systemic sclerosis: a possible target for therapy","volume":"10","author":"Bosello","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib185","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/ar2965","article-title":"B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial","volume":"12","author":"Bosello","year":"2010","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib186","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cei.13238","article-title":"The immunopathogenesis of fibrosis in systemic sclerosis","volume":"195","author":"Brown","year":"2019","journal-title":"Clin. Exp. Immunol."},{"issue":"24","key":"10.1016\/j.smim.2022.101648_bib187","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249544","article-title":"Angiopoietin-2 promotes inflammatory activation in monocytes of systemic sclerosis patients","volume":"21","author":"Carvalheiro","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib188","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1002\/art.39797","article-title":"An autotaxin\/lysophosphatidic acid\/interleukin-6 amplification loop drives scleroderma fibrosis","volume":"68","author":"Castelino","year":"2016","journal-title":"Arthritis Rheuma"},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib189","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1399-0039.2012.01915.x","article-title":"No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis","volume":"80","author":"C\u00e9nit","year":"2012","journal-title":"Tissue Antigens"},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib190","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3899\/jrheum.120506","article-title":"Influence of the IL6 gene in susceptibility to systemic sclerosis","volume":"39","author":"C\u00e9nit","year":"2012","journal-title":"J. Rheuma"},{"key":"10.1016\/j.smim.2022.101648_bib191","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.imlet.2017.09.007","article-title":"Is there a role for IL-17 in the pathogenesis of systemic sclerosis?","volume":"195","author":"Chizzolini","year":"2018","journal-title":"Immunol. Lett."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib192","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/ar3167","article-title":"The cytokine language of monocytes and macrophages in systemic sclerosis","volume":"12","author":"Christmann","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib193","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cei.12111","article-title":"Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy","volume":"173","author":"Cipriani","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib194","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13075-015-0575-8","article-title":"Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis","volume":"17","author":"Clark","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.smim.2022.101648_bib195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-med-041818-011649","article-title":"Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation","volume":"71","author":"Cook","year":"2020","journal-title":"Annu Rev. Med."},{"key":"10.1016\/j.smim.2022.101648_bib196","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clim.2016.09.004","article-title":"The magnitude of cytokine production by stimulated CD56(+) cells is associated with early stages of systemic sclerosis","volume":"173","author":"Cossu","year":"2016","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib197","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2174\/1573397116666201113091655","article-title":"Bronchoalveolar lavage in systemic sclerosis patients: a systematic review","volume":"17","author":"da Silva","year":"2021","journal-title":"Curr. Rheuma Rev."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.151964","article-title":"Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters","volume":"225","author":"de Almeida","year":"2020","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib199","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/jcph.863","article-title":"Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis","volume":"57","author":"de Castro","year":"2017","journal-title":"J. Clin. Pharm."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib200","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3899\/jrheum.120725","article-title":"Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis","volume":"40","author":"De Lauretis","year":"2013","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib201","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/rheumatology\/keq094","article-title":"Peripheral T cells from patients with early systemic sclerosis kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role?","volume":"49","author":"De Palma","year":"2010","journal-title":"Rheumatol. (Oxf. )"},{"issue":"4 Suppl 92","key":"10.1016\/j.smim.2022.101648_bib202","first-page":"S3","article-title":"Systemic sclerosis: from pathogenesis to targeted therapy","volume":"33","author":"Denton","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib203","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/annrheumdis-2018-213031","article-title":"Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis","volume":"77","author":"Denton","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib204","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1186\/ar4672","article-title":"Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis","volume":"16","author":"Desallais","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093161","article-title":"Sildenafil reduces expression and release of IL-6 and IL-8 induced by reactive oxygen species in systemic sclerosis fibroblasts","volume":"21","author":"Di Luigi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib206","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/art.39417","article-title":"Circulating apoptotic microparticles in systemic lupus erythematosus patients drive the activation of dendritic cell subsets and prime neutrophils for NETosis","volume":"68","author":"Dieker","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib207","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/art.40016","article-title":"Scleroderma peripheral B lymphocytes secrete interleukin-6 and transforming growth factor \u03b2 and activate fibroblasts","volume":"69","author":"Dumoitier","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib208","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13075-020-02153-8","article-title":"Inhibition of effector B cells by ibrutinib in systemic sclerosis","volume":"22","author":"Einhaus","year":"2020","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib209","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.arcmed.2009.11.005","article-title":"Taurine: a potential novel addition to the anti-systemic sclerosis weaponry","volume":"41","author":"Fallahzadeh","year":"2010","journal-title":"Arch. Med. Res."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib210","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.autrev.2012.05.004","article-title":"Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases","volume":"12","author":"Fenoglio","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib211","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.autrev.2017.10.015","article-title":"Altered B lymphocyte homeostasis and functions in systemic sclerosis","volume":"17","author":"Forestier","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib212","doi-asserted-by":"crossref","first-page":"R168","DOI":"10.1186\/ar4352","article-title":"B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis","volume":"15","author":"Fran\u00e7ois","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"4 Suppl 91","key":"10.1016\/j.smim.2022.101648_bib213","first-page":"S179","article-title":"Protective role of interleukin-6 in systemic sclerosis gastrointestinal tract involvement: case report and review of the literature","volume":"33","author":"Frech","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib214","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00281-015-0503-7","article-title":"Role of innate immune system in systemic sclerosis","volume":"37","author":"Fullard","year":"2015","journal-title":"Semin Immunopathol."},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib215","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.autrev.2015.07.008","article-title":"Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature","volume":"14","author":"Giuggioli","year":"2015","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib216","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10753-018-0907-3","article-title":"Statins inhibit cytokines in a dose-dependent response in patients with systemic sclerosis","volume":"42","author":"Gon\u00e7alves","year":"2019","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib217","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916934.2017.1416467","article-title":"IL-17 and related cytokines involved in systemic sclerosis: perspectives","volume":"51","author":"Gon\u00e7alves","year":"2018","journal-title":"Autoimmunity"},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib218","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/exd.13982","article-title":"CCL3, IL-7, IL-13 and IFN\u03b3 transcripts are increased in skin\u2019s biopsy of systemic sclerosis","volume":"28","author":"Gon\u00e7alves","year":"2019","journal-title":"Exp. Dermatol."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib219","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.17219\/acem\/68627","article-title":"Serum osteopontin and vitronectin levels in systemic sclerosis","volume":"26","author":"Gundogdu","year":"2017","journal-title":"Adv. Clin. Exp. Med"},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib220","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/03009740903124416","article-title":"Exercise in systemic sclerosis intensifies systemic inflammation and oxidative stress","volume":"39","author":"Hargard\u00f3ttir","year":"2010","journal-title":"Scand. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib221","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10067-010-1610-4","article-title":"Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis","volume":"30","author":"Hasegawa","year":"2011","journal-title":"Clin. Rheumatol."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib222","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/RHU.0000000000001112","article-title":"Vitamin D and cytokine profiles in patients with systemic sclerosis","volume":"26","author":"Hax","year":"2020","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.smim.2022.101648_bib223","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/cells10082053","article-title":"The cell-permeable derivative of the immunoregulatory metabolite itaconate, 4-Octyl itaconate, is anti-fibrotic in systemic sclerosis","volume":"10","author":"Henderson","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib224","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.37738","article-title":"Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts","volume":"65","author":"H\u00fcgle","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib225","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1093\/rheumatology\/ket131","article-title":"Relationship between interleukin-6 and cardiac involvement in systemic sclerosis","volume":"52","author":"Jurisic","year":"2013","journal-title":"Rheumatol. (Oxf. )"},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib226","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s00296-019-04402-9","article-title":"Serum YKL-40 and IL-6 levels correlate with ultrasound findings of articular and periarticular involvement in patients with systemic sclerosis","volume":"39","author":"Karalilova","year":"2019","journal-title":"Rheumatol. Int."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib227","first-page":"26","article-title":"Fibrotic cytokine interplay in evaluation of disease activity in treatment na\u00efve systemic sclerosis patients from Western India","volume":"67","author":"Khadilkar","year":"2019","journal-title":"J. Assoc. Physicians India"},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib228","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","article-title":"Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis","volume":"71","author":"Khan","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib229","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir. Med"},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10067-013-2346-8","article-title":"Serum galectin-3 level in systemic sclerosis","volume":"33","author":"Koca","year":"2014","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib231","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1038\/s41467-021-26099-w","article-title":"Interleukin-31 promotes fibrosis and T helper 2 polarization in systemic sclerosis","volume":"12","author":"Kuzumi","year":"2021","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib232","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/03009742.2017.1378714","article-title":"Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension","volume":"47","author":"Kylhammar","year":"2018","journal-title":"Scand. J. Rheumatol."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib233","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.semarthrit.2015.10.013","article-title":"A review of the effects of statins in systemic sclerosis","volume":"45","author":"Ladak","year":"2016","journal-title":"Semin Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib234","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110820","article-title":"Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis","volume":"10","author":"Lakota","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib235","first-page":"165","article-title":"Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3\u03b5 as potential biomarkers","volume":"58","author":"Landi","year":"2019","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.smim.2022.101648_bib236","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s13075-015-0881-1","article-title":"The HLA-B*35 allele modulates ER stress, inflammation and proliferation in PBMCs from limited cutaneous systemic sclerosis patients","volume":"17","author":"Lenna","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"16","key":"10.1016\/j.smim.2022.101648_bib237","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140458","article-title":"CD47 prevents the elimination of diseased fibroblasts in scleroderma","volume":"5","author":"Lerbs","year":"2020","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib238","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030894","article-title":"Distinct properties of human M-CSF and GM-CSF monocyte-derived macrophages to simulate pathological lung conditions in vitro: application to systemic and inflammatory disorders with pulmonary involvement","volume":"19","author":"Lescoat","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib239","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1093\/rheumatology\/keab257","article-title":"Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients","volume":"60","author":"Lima-J\u00fanior","year":"2021","journal-title":"Rheumatol. (Oxf.)"},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib240","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/rheumatology\/keaa669","article-title":"Imbalance toward TFH 1 cells playing a role in aberrant B cell differentiation in systemic sclerosis","volume":"60","author":"Ly","year":"2021","journal-title":"Rheumatol. (Oxf. )"},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib241","first-page":"146","article-title":"Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. a phase I\/II biomarker trial","volume":"36 Suppl 113","author":"Mantero","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib242","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13075-020-02266-0","article-title":"The role of the oncostatin M\/OSM receptor \u03b2 axis in activating dermal microvascular endothelial cells in systemic sclerosis","volume":"22","author":"Marden","year":"2020","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.smim.2022.101648_bib243","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3389\/fimmu.2018.03056","article-title":"iNOS activity is required for the therapeutic effect of mesenchymal stem cells in experimental systemic sclerosis","volume":"9","author":"Maria","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.smim.2022.101648_bib244","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/138751","article-title":"Proinflammatory effects of diesel exhaust nanoparticles on scleroderma skin cells","volume":"2014","author":"Mastrofrancesco","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib245","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2018.11.008","article-title":"Regulatory and effector B cells: friends or foes?","volume":"93","author":"Matsushita","year":"2019","journal-title":"J. Dermatol. Sci."},{"issue":"2 Suppl 76","key":"10.1016\/j.smim.2022.101648_bib246","first-page":"140","article-title":"Prolonged treatment with transcutaneous electrical nerve stimulation (TENS) modulates neuro-gastric motility and plasma levels of vasoactive intestinal peptide (VIP), motilin and interleukin-6 (IL-6) in systemic sclerosis","volume":"31","author":"McNearney","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib247","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3899\/jrheum.111423","article-title":"Interleukin 6 in systemic sclerosis and potential implications for targeted therapy","volume":"39","author":"Muangchan","year":"2012","journal-title":"J. Rheumatol."},{"issue":"2 Suppl 76","key":"10.1016\/j.smim.2022.101648_bib248","first-page":"122","article-title":"The significance of interleukin-6 and C-reactive protein in systemic sclerosis: a systematic literature review","volume":"31","author":"Muangchant","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib249","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/BOR.0b013e3283456797","article-title":"The value of blocking IL-6 outside of rheumatoid arthritis: current perspective","volume":"23","author":"Murakami","year":"2011","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib250","doi-asserted-by":"crossref","DOI":"10.1152\/ajplung.00173.2020","article-title":"Lysyl oxidase directly contributes to extracellular matrix production and fibrosis in systemic sclerosis","volume":"320","author":"Nguyen","year":"2021","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib251","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/1346-8138.14580","article-title":"Rapid alteration of serum interleukin-6 levels may predict the reactivity of i.v. cyclophosphamide pulse therapy in systemic sclerosis-associated interstitial lung disease","volume":"45","author":"Numajiri","year":"2018","journal-title":"J. Dermatol."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib252","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/imm.12260","article-title":"Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-\u03baB","volume":"143","author":"O'Reilly","year":"2014","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib253","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cytogfr.2012.04.003","article-title":"Interleukin-6, its role in fibrosing conditions","volume":"23","author":"O\u2019Reilly","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib254","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","article-title":"T cells in systemic sclerosis: a reappraisal","volume":"51","author":"O\u2019Reilly","year":"2012","journal-title":"Rheumatol. (Oxf. )"},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib255","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1346-8138.2010.00883.x","article-title":"Serum interleukin-6 level is reflected in elevated high-sensitivity C-reactive protein level in patients with systemic sclerosis","volume":"37","author":"Ohtsuka","year":"2010","journal-title":"J. Dermatol."},{"key":"10.1016\/j.smim.2022.101648_bib256","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3389\/fimmu.2020.00822","article-title":"Fatty acid and carnitine metabolism are dysregulated in systemic sclerosis patients","volume":"11","author":"Ottria","year":"2020","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib257","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10067-010-1649-2","article-title":"Visfatin levels and intima-media thicknesses in rheumatic diseases","volume":"30","author":"Ozgen","year":"2011","journal-title":"Clin. Rheumatol."},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib258","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/rheumatology\/kex347","article-title":"Role of STAT3 in skin fibrosis and transforming growth factor beta signalling","volume":"57","author":"Pedroza","year":"2018","journal-title":"Rheumatol. (Oxf. )"},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib259","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jid.2018.10.027","article-title":"The regulation of skin fibrosis in systemic sclerosis by extracellular ATP via P2Y(2) purinergic receptor","volume":"139","author":"Perera","year":"2019","journal-title":"J. Invest Dermatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13075-017-1252-x","article-title":"Multiplex serum protein analysis reveals potential mechanisms and markers of response to hyperimmune caprine serum in systemic sclerosis","volume":"19","author":"Quillinan","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib261","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13075-018-1689-6","article-title":"Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts","volume":"20","author":"Raschi","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib262","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13075-020-02360-3","article-title":"Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis","volume":"22","author":"Raschi","year":"2020","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib263","first-page":"15","article-title":"Cytokine imbalance in patients with systemic sclerosis and resilience: the key role of interleukin-6","volume":"37 Suppl 119","author":"Rojas","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib264","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/rheumatology\/ket331","article-title":"Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension","volume":"53","author":"Ruiter","year":"2014","journal-title":"Rheumatol. (Oxf. )"},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib265","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/art.41659","article-title":"Dysfunctional keratinocytes increase dermal inflammation in systemic sclerosis: results from studies using tissue-engineered scleroderma epidermis","volume":"73","author":"Russo","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib266","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/art.41418","article-title":"Bioactive plasma mitochondrial DNA is associated with disease progression in scleroderma-associated interstitial lung disease","volume":"72","author":"Ryu","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.smim.2022.101648_bib267","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.2147\/DDDT.S99696","article-title":"Spotlight on tocilizumab and its potential in the treatment of systemic sclerosis","volume":"10","author":"Sakkas","year":"2016","journal-title":"Drug Des. Devel Ther."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib268","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/rheumatology\/ket411","article-title":"Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound","volume":"53","author":"Schiopu","year":"2014","journal-title":"Rheumatol. (Oxf. )"},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib269","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jdermsci.2019.08.004","article-title":"Inhibitory effect of kaempferol on skin fibrosis in systemic sclerosis by the suppression of oxidative stress","volume":"96","author":"Sekiguchi","year":"2019","journal-title":"J. Dermatol. Sci."},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094365","article-title":"Characterization of long non-coding RNAs in systemic sclerosis monocytes: a potential role for PSMB8-AS1 in altered cytokine secretion","volume":"22","author":"Servaas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib271","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1080\/14397595.2018.1559909","article-title":"The benefits and prospects of interleukin-6 inhibitor on systemic sclerosis","volume":"29","author":"Shima","year":"2019","journal-title":"Mod. Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib272","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/14397595.2018.1452178","article-title":"Add-on tocilizumab versus conventional treatment for systemic sclerosis, and cytokine analysis to identify an endotype to tocilizumab therapy","volume":"29","author":"Shima","year":"2019","journal-title":"Mod. Rheumatol."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib273","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/rheumatology\/keq275","article-title":"The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab","volume":"49","author":"Shima","year":"2010","journal-title":"Rheumatol. (Oxf. )"},{"issue":"21","key":"10.1016\/j.smim.2022.101648_bib274","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111793","article-title":"Autoantibodies from patients with scleroderma renal crisis promote PAR-1 receptor activation and IL-6 production in endothelial cells","volume":"22","author":"Simon","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib275","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/art.41697","article-title":"A Proinflammatory cytokine network profile in Th1\/Type 1 effector B cells delineates a common group of patients in four systemic autoimmune diseases","volume":"73","author":"Simon","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib276","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.autrev.2011.01.004","article-title":"Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment","volume":"10","author":"Solt\u00e9sz","year":"2011","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib277","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048560","article-title":"Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts","volume":"7","author":"Steinman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2022.101648_bib278","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41065-019-0091-y","article-title":"Differentially expressed genes between systemic sclerosis and rheumatoid arthritis","volume":"156","author":"Sun","year":"2019","journal-title":"Hereditas"},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib279","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/art.40390","article-title":"Association of defective regulation of autoreactive interleukin-6-producing transitional B lymphocytes with disease in patients with systemic sclerosis","volume":"70","author":"Taher","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib280","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/1346-8138.13827","article-title":"Critical contribution of the interleukin-6\/signal transducer and activator of transcription 3 axis to vasculopathy associated with systemic sclerosis","volume":"44","author":"Taniguchi","year":"2017","journal-title":"J. Dermatol."},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib281","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00403-017-1786-4","article-title":"A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis","volume":"309","author":"Taniguchi","year":"2017","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.smim.2022.101648_bib282","doi-asserted-by":"crossref","first-page":"34012","DOI":"10.1038\/srep34012","article-title":"Mechanistic insight into the norepinephrine-induced fibrosis in systemic sclerosis","volume":"6","author":"Uehara","year":"2016","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib283","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/ard.2009.128207","article-title":"Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis","volume":"69","author":"van Bon","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib284","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41598-018-36314-2","article-title":"Deciphering the potential pharmaceutical mechanism of GUI-ZHI-FU-LING-WAN on systemic sclerosis based on systems biology approaches","volume":"9","author":"Wang","year":"2019","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib285","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/art.40171","article-title":"CCL2 in the circulation predicts long-term progression of interstitial lung disease in patients with early systemic sclerosis: data from two independent cohorts","volume":"69","author":"Wu","year":"2017","journal-title":"Arthritis Rheuma"},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib286","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/BOR.0000000000000215","article-title":"B-cells in systemic sclerosis: emerging evidence from genetics to phenotypes","volume":"27","author":"Wu","year":"2015","journal-title":"Curr. Opin. Rheuma"},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib287","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242863","article-title":"Transcriptional insights into pathogenesis of cutaneous systemic sclerosis using pathway driven meta-analysis assisted by machine learning methods","volume":"15","author":"Xu","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib288","first-page":"110","article-title":"The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations","volume":"34 Suppl 100","author":"Yal\u00e7inkaya","year":"2016","journal-title":"Clin. Exp. Rheuma"},{"key":"10.1016\/j.smim.2022.101648_bib289","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mvr.2016.07.002","article-title":"Capillaroscopic findings and vascular biomarkers in systemic sclerosis: association of low CD40L levels with late scleroderma pattern","volume":"108","author":"Yal\u00e7\u0131nkaya","year":"2016","journal-title":"Micro Res"},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib290","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1586\/eci.11.26","article-title":"Deciphering the genetic background of systemic sclerosis","volume":"7","author":"Broen","year":"2011","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib291","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054419","article-title":"The systemic lupus erythematosus IRF5 risk haplotype is associated with systemic sclerosis","volume":"8","author":"Carmona","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib292","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3899\/jrheum.091163","article-title":"Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity","volume":"37","author":"Dieude","year":"2010","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib293","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/art.24183","article-title":"Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis","volume":"60","author":"Dieude","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib294","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/art.24688","article-title":"STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis","volume":"60","author":"Dieud\u00e9","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib295","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/ard.2010.131243","article-title":"NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis","volume":"70","author":"Dieud\u00e9","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib296","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/rheumatology\/key281","article-title":"Analysis of the genetic component of systemic sclerosis in Iranian and Turkish populations through a genome-wide association study","volume":"58","author":"Gonz\u00e1lez-Serna","year":"2019","journal-title":"Rheumatol. (Oxf. )"},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib297","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/art.24600","article-title":"Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population","volume":"60","author":"Ito","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib298","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/hmg\/dds099","article-title":"Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up","volume":"21","author":"Martin","year":"2012","journal-title":"Hum. Mol. Genet"},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib299","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.4238\/2014.June.16.6","article-title":"Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis","volume":"13","author":"Tang","year":"2014","journal-title":"Genet Mol. Res."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib300","article-title":"Pathophysiology of systemic sclerosis","volume":"50","author":"Thoreau","year":"2021","journal-title":"Presse Med."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib301","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jid.2019.06.147","article-title":"An allele-specific functional SNP associated with two systemic autoimmune diseases modulates IRF5 expression by long-range chromatin loop formation","volume":"140","author":"Thynn","year":"2020","journal-title":"J. Invest Dermatol."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib302","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/039463201402700420","article-title":"Association of the IRF5 SNP rs2004640 with systemic sclerosis in Han Chinese","volume":"27","author":"Wang","year":"2014","journal-title":"Int J. Immunopathol. Pharm."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib303","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/ijd.12839","article-title":"Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis","volume":"55","author":"Xu","year":"2016","journal-title":"Int J. Dermatol."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib304","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1586\/eci.11.40","article-title":"Novel insights on the role of the innate immune system in systemic sclerosis","volume":"7","author":"York","year":"2011","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib305","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13075-015-0572-y","article-title":"Identification of NF-\u03baB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis","volume":"17","author":"Arismendi","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib306","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.jid.2021.02.015","article-title":"Downregulated IRF8 in monocytes and macrophages of patients with systemic sclerosis may aggravate the fibrotic phenotype","volume":"141","author":"Ototake","year":"2021","journal-title":"J. Invest Dermatol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib307","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/art.37777","article-title":"PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population","volume":"65","author":"Terao","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib308","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1136\/ard.2010.148874","article-title":"Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis","volume":"70","author":"Carmona","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib309","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3899\/jrheum.101053","article-title":"Association study of ITGAM, ITGAX, and CD58 autoimmune risk loci in systemic sclerosis: results from 2 large European Caucasian cohorts","volume":"38","author":"Coustet","year":"2011","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib310","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s10067-008-0960-7","article-title":"Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis","volume":"27","author":"Becker","year":"2008","journal-title":"Clin. Rheumatol."},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib311","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3899\/jrheum.161369","article-title":"An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis","volume":"44","author":"Bossini-Castillo","year":"2017","journal-title":"J. Rheumatol."},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib312","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/rheumatology\/ker259","article-title":"Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population","volume":"50","author":"Bossini-Castillo","year":"2011","journal-title":"Rheumatol. (Oxf. )"},{"issue":"4 Suppl 91","key":"10.1016\/j.smim.2022.101648_bib313","first-page":"S98","article-title":"Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis","volume":"33","author":"Corallo","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib314","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-2249.2008.03637.x","article-title":"Up-regulated macrophage migration inhibitory factor protects apoptosis of dermal fibroblasts in patients with systemic sclerosis","volume":"152","author":"Kim","year":"2008","journal-title":"Clin. Exp. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib315","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/ard.62.5.460","article-title":"Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis","volume":"62","author":"Selvi","year":"2003","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib316","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4081\/reumatismo.2014.774","article-title":"Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor \u03b2 in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension","volume":"66","author":"Stefanantoni","year":"2015","journal-title":"Reumatismo"},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib317","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/art.22179","article-title":"Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma","volume":"54","author":"Wu","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib318","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/annrheumdis-2018-214127","article-title":"Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases","volume":"78","author":"Acosta-Herrera","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib319","first-page":"306","article-title":"Transcriptional activity of nuclear factor \u03baB family genes in patients with systemic sclerosis","volume":"47","author":"Lis-\u015awi\u0119ty","year":"2017","journal-title":"Ann. Clin. Lab Sci."},{"key":"10.1016\/j.smim.2022.101648_bib320","article-title":"Association of GTF2I, NFKB1, and TYK2 regional polymorphisms with systemic sclerosis in a Chinese Han population","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib321","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/sji.12020","article-title":"Interleukin-10 gene promoter and NFKB1 promoter insertion\/deletion polymorphisms in systemic sclerosis","volume":"77","author":"Salim","year":"2013","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib322","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s12891-016-1320-4","article-title":"Association of a rare NOTCH4 coding variant with systemic sclerosis: a family-based whole exome sequencing study","volume":"17","author":"Cardinale","year":"2016","journal-title":"BMC Musculoskelet. Disord."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib323","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3899\/jrheum.180094","article-title":"Associations of multiple NOTCH4 exonic variants with systemic sclerosis","volume":"46","author":"Zhou","year":"2019","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib324","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/annrheumdis-2011-200275","article-title":"Novel identification of the IRF7 region as an anticentromere autoantibody propensity locus in systemic sclerosis","volume":"71","author":"Carmona","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib325","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/annrheumdis-2012-201888","article-title":"Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study","volume":"72","author":"Bossini-Castillo","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib326","doi-asserted-by":"crossref","first-page":"46","DOI":"10.14715\/cmb\/2018.64.5.7","article-title":"Association between the functional PTPN22 G788A (R263Q) polymorphism and susceptibility to autoimmune diseases: a meta-analysis","volume":"64","author":"Bae","year":"2018","journal-title":"Cell Mol. Biol. (Noisy-Le. -Gd. )"},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib327","first-page":"321","article-title":"Lack of association of the PTPN22 gene polymorphism R620W with systemic sclerosis","volume":"24","author":"Balada","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib328","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/ard.2010.130138","article-title":"Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis","volume":"70","author":"Diaz-Gallo","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib329","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.23601","article-title":"The PTPN22 620W allele confers susceptibility to systemic sclerosis: findings of a large case-control study of European Caucasians and a meta-analysis","volume":"58","author":"Dieud\u00e9","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib330","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1002\/art.22196","article-title":"Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis","volume":"54","author":"Gourh","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib331","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.41291","article-title":"Pleiotropy in the genetic predisposition to rheumatoid arthritis: a phenome-wide association study and inverse variance-weighted meta-analysis","volume":"72","author":"Kawai","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib332","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s11033-011-1074-x","article-title":"The association between the PTPN22 C1858T polymorphism and systemic sclerosis: a meta-analysis","volume":"39","author":"Lee","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib333","first-page":"520","article-title":"The PTPN22 C1858T variant as a risk factor for rheumatoid arthritis and systemic lupus erythematosus but not for systemic sclerosis in the Colombian population","volume":"30","author":"Ramirez","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib334","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/ard.2005.048181","article-title":"Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)*620W allele and systemic sclerosis in the French Caucasian population","volume":"65","author":"Wipff","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib335","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1684\/ejd.2019.3645","article-title":"Memory CD4+ T cells lacking expression of CCR7 promote pro-inflammatory cytokine production in patients with diffuse cutaneous systemic sclerosis","volume":"29","author":"Almanzar","year":"2019","journal-title":"Eur. J. Dermatol."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib336","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/s10165-011-0574-9","article-title":"A meta-analysis of the association between cytokine gene polymorphisms and systemic sclerosis","volume":"22","author":"Peng","year":"2012","journal-title":"Mod. Rheumatol."},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib337","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/hmg\/ddp119","article-title":"The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype","volume":"18","author":"Rueda","year":"2009","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib338","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/ard.2009.111310","article-title":"Association of STAT4 polymorphism with systemic sclerosis in a Japanese population","volume":"68","author":"Tsuchiya","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib339","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/039463201302600220","article-title":"STAT4 is a genetic risk factor for systemic sclerosis in a Chinese population","volume":"26","author":"Yi","year":"2013","journal-title":"Int J. Immunopathol. Pharm."},{"key":"10.1016\/j.smim.2022.101648_bib340","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6064830","article-title":"Reassessing the role of the active TGF-\u03b21 as a biomarker in systemic sclerosis: association of serum levels with clinical manifestations","volume":"2016","author":"Dantas","year":"2016","journal-title":"Dis. Markers"},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib341","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/rheumatology\/kei088","article-title":"Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score","volume":"44","author":"Dziadzio","year":"2005","journal-title":"Rheumatol. (Oxf. )"},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib342","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1183\/09031936.05.00133404","article-title":"Genetics of fibrosing lung diseases","volume":"25","author":"Grutters","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib343","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00403-004-0472-5","article-title":"Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis","volume":"296","author":"Hasegawa","year":"2004","journal-title":"Arch. Dermatol. Res."},{"issue":"23","key":"10.1016\/j.smim.2022.101648_bib344","doi-asserted-by":"crossref","first-page":"14026","DOI":"10.1111\/jcmm.16013","article-title":"Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis","volume":"24","author":"Henderson","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"10","key":"10.1016\/j.smim.2022.101648_bib345","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8","article-title":"Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis","volume":"43","author":"Jelaska","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib346","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1124\/mol.105.017483","article-title":"Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression","volume":"69","author":"Jinnin","year":"2006","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib347","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98380","article-title":"pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis","volume":"3","author":"Kafaja","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib348","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/art.11364","article-title":"Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors","volume":"50","author":"Kawaguchi","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib349","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1399-0039.2004.00185.x","article-title":"Transforming growth factor-beta1 polymorphisms in Korean patients with systemic sclerosis","volume":"63","author":"Lee","year":"2004","journal-title":"Tissue Antigens"},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib350","first-page":"275","article-title":"Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis","volume":"33","author":"Matsushita","year":"2006","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib351","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0002-9440(10)62362-0","article-title":"Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts","volume":"166","author":"Mimura","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib352","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/thoraxjnl-2011-200717","article-title":"Proteasomal inhibition after injury prevents fibrosis by modulating TGF-\u03b2(1) signalling","volume":"67","author":"Mutlu","year":"2012","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib353","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jdermsci.2019.02.003","article-title":"COA-Cl prevented TGF-\u03b21-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis","volume":"94","author":"Nakai","year":"2019","journal-title":"J. Dermatol. Sci."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib354","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134092","article-title":"Partially evoked epithelial-mesenchymal transition (EMT) is associated with increased TGF\u03b2 signaling within lesional scleroderma skin","volume":"10","author":"Nikitorowicz-Buniak","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.smim.2022.101648_bib355","doi-asserted-by":"crossref","first-page":"25066","DOI":"10.1038\/srep25066","article-title":"IL-13 mediates collagen deposition via STAT6 and microRNA-135b: a role for epigenetics","volume":"6","author":"O\u2019Reilly","year":"2016","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib356","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/exd.12256","article-title":"Bleomycin inhibits adipogenesis and accelerates fibrosis in the subcutaneous adipose layer through TGF-\u03b21","volume":"22","author":"Ohgo","year":"2013","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib357","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2133.2002.04947.x","article-title":"The polymorphism of transforming growth factor-beta1 gene in Japanese patients with systemic sclerosis","volume":"147","author":"Ohtsuka","year":"2002","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib358","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.clim.2013.03.001","article-title":"Ghrelin attenuates collagen production in lesional fibroblasts from patients with systemic sclerosis","volume":"147","author":"Ota","year":"2013","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib359","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/art.40326","article-title":"The antiretroviral agent nelfinavir mesylate: a potential therapy for systemic sclerosis","volume":"70","author":"Sanchez","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib360","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/08977194.2015.1010645","article-title":"The immune suppressive function of transforming growth factor-\u03b2 (TGF-\u03b2) in human diseases","volume":"33","author":"Sheng","year":"2015","journal-title":"Growth Factors"},{"key":"10.1016\/j.smim.2022.101648_bib361","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106886","article-title":"Aryl hydrocarbon receptor signaling activation in systemic sclerosis attenuates collagen production and is a potential antifibrotic target","volume":"88","author":"Shi","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.smim.2022.101648_bib362","first-page":"1","article-title":"MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program","volume":"7","author":"Wang","year":"2021","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib363","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213400","article-title":"A potential new approach for treating systemic sclerosis: dedifferentiation of SSc fibroblasts and change in the microenvironment by blocking store-operated Ca2+ entry","volume":"14","author":"Wu","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib364","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jid.2019.11.032","article-title":"Function-blocking RHAMM peptides attenuate fibrosis and promote antifibrotic adipokines in a bleomycin-induced murine model of systemic sclerosis","volume":"141","author":"Wu","year":"2021","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.smim.2022.101648_bib365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.imlet.2017.09.011","article-title":"Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy","volume":"195","author":"Bhattacharyya","year":"2018","journal-title":"Immunol. Lett."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib366","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13075-016-1118-7","article-title":"A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator","volume":"18","author":"Bhattacharyya","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib367","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1136\/ard.2009.127928","article-title":"Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population","volume":"69","author":"Dieud\u00e9","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib368","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189498","article-title":"Gene-level association analysis of systemic sclerosis: a comparison of African-Americans and White populations","volume":"13","author":"Gorlova","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib369","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1002\/art.34490","article-title":"Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity","volume":"64","author":"Koumakis","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib370","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/annrheumdis-2016-210645","article-title":"Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis","volume":"76","author":"Terao","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib371","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/art.39476","article-title":"Identification of an association of TNFAIP3 polymorphisms with matrix metalloproteinase expression in fibroblasts in an integrative study of systemic sclerosis-associated genetic and environmental factors","volume":"68","author":"Wei","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib372","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.2010.141838","article-title":"A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort","volume":"70","author":"Bossini-Castillo","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib373","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3899\/jrheum.111270","article-title":"Independent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosis","volume":"39","author":"Coustet","year":"2012","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib374","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrd.2016.144","article-title":"Inflammatory disease: T cell-targeted antibody reverses fibrosis","volume":"15","author":"Crunkhorn","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib375","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/rheumatology\/kez015","article-title":"Association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis-related calcinosis","volume":"58","author":"Duffus","year":"2019","journal-title":"Rheumatol. (Oxf. )"},{"issue":"27","key":"10.1016\/j.smim.2022.101648_bib376","doi-asserted-by":"crossref","first-page":"E3901","DOI":"10.1073\/pnas.1523512113","article-title":"OX40L blockade protects against inflammation-driven fibrosis","volume":"113","author":"Elhai","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib377","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard.2009.116434","article-title":"Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis","volume":"69","author":"Gourh","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.smim.2022.101648_bib378","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3899\/jrheum.080120","article-title":"Increased serum soluble OX40 in patients with systemic sclerosis","volume":"35","author":"Komura","year":"2008","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib379","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cytogfr.2012.04.002","article-title":"Emerging roles for TNIP1 in regulating post-receptor signaling","volume":"23","author":"Ramirez","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib380","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1186\/ar4217","article-title":"Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis","volume":"15","author":"Avouac","year":"2013","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib381","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/rheumatology\/ker447","article-title":"Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis","volume":"51","author":"Carrai","year":"2012","journal-title":"Rheumatol. (Oxf. )"},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib382","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s13075-014-0442-z","article-title":"Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features","volume":"16","author":"Cipriani","year":"2014","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib383","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13075-016-1122-y","article-title":"Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study","volume":"18","author":"Corallo","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib384","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/rheumatology\/kew017","article-title":"Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients","volume":"55","author":"Cossu","year":"2016","journal-title":"Rheumatol. (Oxf. )"},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib385","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.humpath.2005.10.007","article-title":"The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis","volume":"37","author":"Davies","year":"2006","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib386","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/mol.65.2.389","article-title":"Bucillamine induces the synthesis of vascular endothelial growth factor dose-dependently in systemic sclerosis fibroblasts via nuclear factor-kappaB and simian virus 40 promoter factor 1 pathways","volume":"65","author":"Distler","year":"2004","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib387","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/ard.2010.140657","article-title":"Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease","volume":"70","author":"Distler","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib388","first-page":"508","article-title":"Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis--association with pulmonary involvement","volume":"24","author":"Dziankowska-Bartkowiak","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.smim.2022.101648_bib389","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1573397114666180809121005","article-title":"The Role of Vascular Endothelial Growth Factor in Systemic Sclerosis","volume":"15","author":"Flower","year":"2019","journal-title":"Curr. Rheumatol. Rev."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib390","first-page":"24","article-title":"Parasympathetic activity increases with digital microvascular damage and vascular endothelial growth factor in systemic sclerosis","volume":"36 Suppl 113","author":"Gigante","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.smim.2022.101648_bib391","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.mvr.2017.06.003","article-title":"Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy","volume":"114","author":"Gigante","year":"2017","journal-title":"Micro Res."},{"key":"10.1016\/j.smim.2022.101648_bib392","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ejim.2018.04.017","article-title":"Erectile dysfunction: Imbalance between pro-angiogenic and anti-angiogenic factors in systemic sclerosis","volume":"53","author":"Gigante","year":"2018","journal-title":"Eur. J. Intern Med."},{"key":"10.1016\/j.smim.2022.101648_bib393","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.resp.2014.10.018","article-title":"Pro- and antiangiogenic markers in patients with pulmonary complications of systemic scleroderma","volume":"209","author":"Glodkowska-Mrowka","year":"2015","journal-title":"Respir. Physiol. Neurobiol."},{"issue":"11","key":"10.1016\/j.smim.2022.101648_bib394","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1136\/ard.2011.150607","article-title":"Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro","volume":"70","author":"Guiducci","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.smim.2022.101648_bib395","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/BOR.0000000000000332","article-title":"Recent advances in the pathogenesis and management of Raynaud\u2019s phenomenon and digital ulcers","volume":"28","author":"Herrick","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib396","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jamadermatol.2018.0916","article-title":"Whole-body distribution and clinical association of telangiectases in systemic sclerosis","volume":"154","author":"Jouvray","year":"2018","journal-title":"JAMA Dermatol."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib397","first-page":"102","article-title":"Prediction of organ involvement in systemic sclerosis by serum biomarkers and peripheral endothelial function","volume":"36 Suppl 113","author":"Kawashiri","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib398","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tcm.2012.05.011","article-title":"Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant","volume":"21","author":"Manetti","year":"2011","journal-title":"Trends Cardiovasc Med."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib399","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1136\/annrheumdis-2012-203183","article-title":"Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis","volume":"72","author":"Manetti","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.smim.2022.101648_bib400","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/CIRCRESAHA.111.242057","article-title":"Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis","volume":"109","author":"Manetti","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.smim.2022.101648_bib401","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108364","article-title":"CD21(low) B cells in systemic sclerosis: a possible marker of vascular complications","volume":"213","author":"Marrapodi","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.smim.2022.101648_bib402","article-title":"Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity","volume":"125","author":"Michalska-Jakubus","year":"2019","journal-title":"Micro Res."},{"issue":"5 Suppl 62","key":"10.1016\/j.smim.2022.101648_bib403","first-page":"S19","article-title":"Low circulating level of CD133+KDR+cells in patients with systemic sclerosis","volume":"28","author":"Mok","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.smim.2022.101648_bib404","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.tripleo.2007.07.021","article-title":"The immunohistochemical analysis of vascular endothelial growth factors A and C and microvessel density in gingival tissues of systemic sclerosis patients: their possible effects on gingival inflammation","volume":"105","author":"Ozcelik","year":"2008","journal-title":"Oral. Surg. Oral. Med Oral. Pathol. Oral. Radiol. Endod."},{"key":"10.1016\/j.smim.2022.101648_bib405","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2466-9-18","article-title":"Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis","volume":"9","author":"Papaioannou","year":"2009","journal-title":"BMC Pulm. Med."},{"issue":"1","key":"10.1016\/j.smim.2022.101648_bib406","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/art.39424","article-title":"Association of acroosteolysis with enhanced osteoclastogenesis and higher blood levels of vascular endothelial growth factor in systemic sclerosis","volume":"68","author":"Park","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib407","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/annrheumdis-2015-207483","article-title":"Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis","volume":"75","author":"Romano","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib408","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s10067-016-3219-8","article-title":"Impaired angiogenesis as a feature of digital ulcers in systemic sclerosis","volume":"35","author":"Silva","year":"2016","journal-title":"Clin. Rheumatol."},{"issue":"4 Suppl 91","key":"10.1016\/j.smim.2022.101648_bib409","first-page":"S127","article-title":"Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients","volume":"33","author":"Silva","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"9","key":"10.1016\/j.smim.2022.101648_bib410","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/rheumatology\/kep154","article-title":"The transport of high amounts of vascular endothelial growth factor by blood platelets underlines their potential contribution in systemic sclerosis angiogenesis","volume":"48","author":"Solanilla","year":"2009","journal-title":"Rheumatol. (Oxf. )"},{"issue":"5","key":"10.1016\/j.smim.2022.101648_bib411","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00296-009-1339-z","article-title":"Effects of shock wave therapy in the skin of patients with progressive systemic sclerosis: a pilot study","volume":"31","author":"Tinazzi","year":"2011","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.smim.2022.101648_bib412","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7649480","article-title":"The role of angiogenesis factors in the formation of vascular changes in scleroderma by assessment of the concentrations of VEGF and sVEGFR2 in blood serum and tear fluid","volume":"2020","author":"Waszczykowska","year":"2020","journal-title":"Mediat. Inflamm."},{"issue":"22","key":"10.1016\/j.smim.2022.101648_bib413","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228703","article-title":"Matrix metalloproteinases MMP-2 and MMP-9, their inhibitors TIMP-1 and TIMP-2, vascular endothelial growth factor and sVEGFR-2 as predictive markers of ischemic retinopathy in patients with systemic sclerosis-case series report","volume":"21","author":"Waszczykowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.smim.2022.101648_bib414","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00296-015-3279-0","article-title":"Polymorphism of VEGF gene in susceptibility to chronic immune-mediated inflammatory diseases: a meta-analysis","volume":"35","author":"Wei","year":"2015","journal-title":"Rheumatol. Int."},{"issue":"7","key":"10.1016\/j.smim.2022.101648_bib415","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/rheumatology\/ken100","article-title":"Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin","volume":"47","author":"Wipff","year":"2008","journal-title":"Rheumatol. (Oxf. )"},{"key":"10.1016\/j.smim.2022.101648_bib416","doi-asserted-by":"crossref","DOI":"10.1002\/art.40898","article-title":"A machine learning classifier for assigning individual patients with systemic sclerosis to intrinsic molecular subsets","author":"Franks","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"D1","key":"10.1016\/j.smim.2022.101648_bib417","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"Suppl 4","key":"10.1016\/j.smim.2022.101648_bib418","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8 Suppl 4","author":"Chin","year":"2014","journal-title":"BMC Syst. Biol."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532322000653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532322000653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:24:55Z","timestamp":1760916295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532322000653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":418,"alternative-id":["S1044532322000653"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2022.101648","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular and Molecular Diversity in Scleroderma","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2022.101648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101648"}}